Buys
Open market- Shares
- Avg price
- Total value
Southpoint Capital Advisors LP - 10%+ Owner at FENNEC PHARMACEUTICALS INC.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- FENC on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Southpoint Capital Advisors LP in FENNEC PHARMACEUTICALS INC.
Sells
Open market- Shares
- -1,332,473
- Avg price
- $7.76
- Total value
- -$10,341,902
Net
Past year- Shares
- -1,332,473
- Share %
- -100%
- Total value
- -$10,341,902
Reported holdings for Southpoint Capital Advisors LP in FENNEC PHARMACEUTICALS INC.
Form 4 holding
10%+ Owner
FENNEC PHARMACEUTICALS INC.
- Security class
- Common Stock
- Shares / value
- 2,744,741
- Estimated value
- $20,585,557
- Report date
- 24 Dec 2025
- Price
- $7.50
- Ownership
- Indirect
Transaction history for Southpoint Capital Advisors LP in FENNEC PHARMACEUTICALS INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.